Between 2017 and 2019, the substituted cathinone N-ethyl pentylone (ephylone) was the most commonly encountered emergent synthetic stimulant to appear in forensic casework. Due to its prevalence and contributions to mortality, N-ethyl pentylone was federally scheduled by the United States Drug Enforcement Administration (DEA) in August 2019. This statute created a shift in the NPS drug market, noted by proliferation of two new synthetic stimulants: Eutylone and Benzylone.
DOWNLOAD THE ALERT
March 31, 2020
Eutylone (bk-EBDB) and Benzylone (BMDP): Increasing Prevalence of New Synthetic Stimulants in the United States
